Chronic lymphocytic leukemia (CLL) is a type of cancer affecting a type of white blood cell in the blood and bone marrow. It ...

Video content above is prompted by the following: Let’s conclude by discussing our perspectives on the future of CLL treatment. How do you envision the CLL patient experience evolving in the coming ...

Expert Rev Hematol. 2013;6(4):441-449. In conclusion, although age should generally determine the goal of treatment in CLL, the patient's functional status rather than chronological age can be ...

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the lymphocytes, a type of white blood cell. CLL begins in the bone marrow and then travels to the blood. It may spread to the ...

Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

HOUSTON — Bruton's tyrosine kinase inhibitors such as ibrutinib, acalabrutinib, and zanubrutinib have revolutionized the ...

CLL gets worse slowly, and many people don't have symptoms at first. Over time, you could have swollen lymph nodes, a fever, a tired feeling, belly pain, night sweats, weight loss, or more ...

Once a doctor diagnoses and stages CLL, they can work with you on a treatment plan. Keep reading to learn more about the CLL flow cytometry test — when doctors use it, how it works, and more.

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It can progress slowly and may not cause many symptoms. Although it is treatable, it’s not ...

The treatment landscape of chronic lymphocytic leukaemia (CLL) was transformed when the small molecule drug ibrutinib ...

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited ...

Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic ...